Bringing the Benefits of eCOA BYOD Strategies to Clinical Studies
pharmaphorum
DECEMBER 13, 2022
This precipitated a shift from a centralised trial experience to a decentralised one, resulting in participants communicating electronically. Both the EMA and FDA have released draft guidance on the issue and are currently soliciting feedback. BYOD in clinical trials. Statistics show there are 6.5
59 
Let's personalize your content